Megahed on the Effects of NGS on First-Line Treatment Decisions in NSCLC

Ahmed Megahed, MBBCh, discusses the rationale for investigating the effects of next-generation sequencing on first-line treatment decisions for patients with stage IV non–small cell lung cancer.

Related Keywords

Ahmed Megahed ,Kaiser Permanente ,Southern California Permanente Medical Group ,Kaiser Permanente Southern California ,Mbbch ,Next Generation Sequencing ,Patients With Stage Iv Non Small Cell Lung Cancer ,